secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0000950170-24-061061
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Bio shareholders approve director elections, equity plan increase, auditor ratification
--------------------------------------------------------------------------------

- James Rolke (122,822 for) and Jess Roper (122,543 for) elected as Class B directors; 461,538 broker non-votes.
- Approved amendment to 2021 Equity Incentive Plan increasing reserved shares from 21,623 to 163,294 (107,447 for, 42,981 against).
- Ratified Baker Tilly US, LLP as auditor for FY2024 with 595,879 for, 18,558 against.
- Quorum achieved with 614,695 shares present (greater than 1/3 of 1,632,935 outstanding shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024061061/0000950170-24-061061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024061061/revb-20240515.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-061061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer